Attached files
| file | filename |
|---|---|
| EX-32.2 - EX-32.2 - AERIE PHARMACEUTICALS INC | aeri12312020ex-322.htm |
| EX-32.1 - EX-32.1 - AERIE PHARMACEUTICALS INC | aeri12312020ex-321.htm |
| EX-31.2 - EX-31.2 - AERIE PHARMACEUTICALS INC | aeri12312020ex-312.htm |
| EX-31.1 - EX-31.1 - AERIE PHARMACEUTICALS INC | aeri12312020ex-311.htm |
| EX-10.32 - EX-10.32 - AERIE PHARMACEUTICALS INC | aeriex-1032aeriepharmaceut.htm |
| EX-4.3 - EX-4.3 - AERIE PHARMACEUTICALS INC | aeriex-43descriptionofther.htm |
| 10-K - 10-K - AERIE PHARMACEUTICALS INC | aeri-20201231.htm |
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the incorporation by reference in the Registration Statements on Form S-8 (Nos. 333-228247, 333-223364, 333-221442, 333-219671, 333-216578, 333-216577 and 333-192030) of Aerie Pharmaceuticals, Inc. of our report dated February 25, 2021 relating to the financial statements and the effectiveness of internal control over financial reporting, which appears in this Form 10-K.
/s/ PricewaterhouseCoopers LLP
Florham Park, New Jersey
February 25, 2021